Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
-
Nephrol. Dial. Transplant. · Feb 2007
Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure.
Prostacyclin is an easy-to-use and safe antihaemostatic drug for continuous renal replacement therapies (RRTs). No study has been performed so far about its use in critically ill patients with acute renal failure (ARF) treated with sustained low-efficiency dialysis (SLED), a hybrid modality between conventional intermittent and continuous RRTs. ⋯ Prostacyclin is a safe and effective antihaemostatic agent for SLED.
-
Nephrol. Dial. Transplant. · Feb 2007
Multicenter StudyA prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
Retrospective studies have shown hospitalization and mortality rates during haemodialysis (HD) to be associated with anaemia. ⋯ Hb level predicted 1-year-survival and hospitalization. This effect persisted after adjustment for comorbidity and other prognostic factors.